Analytical and Bioanalytical Chemistry

, Volume 388, Issue 7, pp 1415–1435 | Cite as

Bioanalytical procedures for determination of drugs of abuse in blood

Review

Abstract

Determination of drugs of abuse in blood is of great importance in clinical and forensic toxicology. This review describes procedures for detection of the following drugs of abuse and their metabolites in whole blood, plasma or serum: Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol glucuronide, heroin, 6-monoacetylmorphine, morphine, morphine-6-glucuronide, morphine-3-glucuronide, codeine, amphetamine, methamphetamine, 3,4-methylenedioxymethamphetamine, N-ethyl-3,4-methylenedioxyamphetamine, 3,4-methylenedioxyamphetamine, cocaine, benzoylecgonine, ecgonine methyl ester, cocaethylene, other cocaine metabolites or pyrolysis products (norcocaine, norcocaethylene, norbenzoylecgonine, m-hydroxycocaine, p-hydroxycocaine, m-hydroxybenzoylecgonine, p-hydroxybenzoylecgonine, ethyl ecgonine, ecgonine, anhydroecgonine methyl ester, anhydroecgonine ethyl ester, anhydroecgonine, noranhydroecgonine, N-hydroxynorcocaine, cocaine N-oxide, anhydroecgonine methyl ester N-oxide). Metabolites and degradation products which are recommended to be monitored for assessment in clinical or forensic toxicology are mentioned. Papers written in English between 2002 and the beginning of 2007 are reviewed. Analytical methods are assessed for their suitability in forensic toxicology, where special requirements have to be met. For many of the analytes sensitive immunological methods for screening are available. Screening and confirmation is mostly done by gas chromatography (GC)–mass spectrometry (MS) or liquid chromatography (LC)–MS(/MS) procedures. Basic information about the biosample assayed, internal standard, workup, GC or LC column and mobile phase, detection mode, and validation data for each procedure is summarized in two tables to facilitate the selection of a method suitable for a specific analytic problem.

Keywords

Drugs of abuse Gas chromatography–mass spectrometry Liquid chromatography–tandem mass spectrometry Blood Determination Forensic toxicology 

Abbreviations

AEME

anhydroecgonine methyl ester

APCI

atmospheric pressure chemical ionization

BZE

benzoylecgonine

CI

chemical ionization

CYP

cytochrome P-450

CZE

capillary zone electrophoresis

DAD

diode array detection

EI

electron ionization

EME

ecgonine methyl ester

ESI

electrospray ionization

GC

gas chromatography

HFBA

heptafluorobutyric anhydride

(S)-HFBPCl

(S)-(-)-heptafluorobutyrylprolyl chloride

HPLC

high-performance liquid chromatography

LC

liquid chromatography

LIF

laser-induced fluorescence

LLE

liquid–liquid extraction

LOQ

limit of quantification

LOD

limit of detection

6-MAM

6-monoacetylmorphine

MDA

3,4-methylenedioxyamphetamine

MDEA

N-ethyl-3,4-methylenedioxyamphetamine

MDMA

3,4-methylenedioxymethamphetamine

M3G

morphine-3-glucuronide

M6G

morphine-6-glucuronide

MRM

multiple reaction monitoring

MS

mass spectrometry

MS/MS

tandem mass spectrometry

(R)-(-)-MTPCl

(R)-(-)-α-methoxy-α-trifluoromethylphenylacetyl chloride

NICI

negative ion chemical ionization

OH-THC

11-hydroxy-Δ9-tetrahydrocannabinol

PICI

positive ion chemical ionization

SIM

selected ion monitoring

SPE

solid-phase extraction

THC

Δ9-tetrahydrocannabinol

THC-COOgluc

11-nor-9-carboxy-Δ9-tetrahydrocannabinol glucuronide

THC-COOH

11-nor-9-carboxy-Δ9-tetrahydrocannabinol

UPLC

ultraperformance liquid chromatography

References

  1. 1.
    Moeller MR, Kraemer T (2002) Ther Drug Monit 24:210–221CrossRefGoogle Scholar
  2. 2.
    Chu MH, Drummer OH (2002) J Anal Toxicol 26:575–581Google Scholar
  3. 3.
    Kroener L, Musshoff F, Madea B (2003) J Anal Toxicol 27:205–212Google Scholar
  4. 4.
    Kupiec T, DeCicco L, Spiehler V, Sneed G, Kemp P (2002) J Anal Toxicol 26:513–518Google Scholar
  5. 5.
    Spiehler V, Isenschmid DS, Matthews P, Kemp P, Kupiec T (2003) J Anal Toxicol 27:587–591Google Scholar
  6. 6.
    Schutz H, Auch J, Erdmann F, Weiler G, Verhoff MA (2006) Arzneimittelforschung 56:414–420Google Scholar
  7. 7.
    Maurer HH (2005) Clin Biochem 38:310–318CrossRefGoogle Scholar
  8. 8.
    Maurer HH (2004) Clin Chem Lab Med 42:1310–1324CrossRefGoogle Scholar
  9. 9.
    Maurer HH, Peters FT (2005) Ther Drug Monit 27:686–688CrossRefGoogle Scholar
  10. 10.
    European Monitoring Centre for Drugs and Drug Addiction (2006) Annual report 2006: the state of the drugs problem in Europe. Office for Official Publications of the European Communities, LuxembourgGoogle Scholar
  11. 11.
    SAMHSA (2005) 2005 National survey on drug use & health: national findings. DHHS publication no SMA 06-4194Google Scholar
  12. 12.
    Huang W, Moody DE, Andrenyak DM, Smith EK, Foltz RL, Huestis MA, Newton JF (2001) J Anal Toxicol 25:531–537Google Scholar
  13. 13.
    Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA (2003) J Chromatogr B 798:145–154CrossRefGoogle Scholar
  14. 14.
    Steinmeyer S, Bregel D, Warth S, Kraemer T, Moeller MR (2002) J Chromatogr B 772:239–248CrossRefGoogle Scholar
  15. 15.
    Giroud C, Menetrey A, Augsburger M, Buclin T, Sanchez-Mazas P, Mangin P (2001) Forensic Sci Int 123:159–164CrossRefGoogle Scholar
  16. 16.
    Skopp G, Potsch L, Mauden M, Richter B (2002) Forensic Sci Int 126:17–23CrossRefGoogle Scholar
  17. 17.
    Teske J, Putzbach K, Engewald W, Muller RK (2002) J Chromatogr B 772:299–306CrossRefGoogle Scholar
  18. 18.
    Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F (2005) J Anal Toxicol 29:782–789Google Scholar
  19. 19.
    Scurlock RD, Ohlson GB, Worthen DK (2006) J Anal Toxicol 30:262–266Google Scholar
  20. 20.
    Maralikova B, Weinmann W (2004) J Mass Spectrom 39:526–531CrossRefGoogle Scholar
  21. 21.
    Yang R, Xie W (2006) Forensic Sci Int 162:135–139CrossRefGoogle Scholar
  22. 22.
    Laloup M, Del Mar Ramirez FM, Wood M, De BG, Maes V, Samyn N (2006) Forensic Sci Int 161:175–179CrossRefGoogle Scholar
  23. 23.
    Skopp G, Potsch L (2002) Clin Chem 48:301–306Google Scholar
  24. 24.
    Abbara C, Galy R, Benyamina A, Reynaud M, Bonhomme-Faivre L (2006) J Pharm Biomed Anal 41:1011–1016CrossRefGoogle Scholar
  25. 25.
    Toennes SW, Kauert GF (2001) J Anal Toxicol 25:339–343Google Scholar
  26. 26.
    Ghazi-Khansari M, Zendehdel R, Pirali-Hamedani M, Amini M (2006) Clin Chim Acta 364:235–238CrossRefGoogle Scholar
  27. 27.
    Emara S, Darwish I, Youssef D, Masujima T (2004) Biomed Chromatogr 18:21–27CrossRefGoogle Scholar
  28. 28.
    Salmon AY, Goren Z, Avissar Y, Soreq H (1999) Clin Exp Pharmacol Physiol 26:596–600CrossRefGoogle Scholar
  29. 29.
    Leis HJ, Fauler G, Raspotnig G, Windischhofer W (2002) J Mass Spectrom 37:395–400CrossRefGoogle Scholar
  30. 30.
    Lotsch J (2005) J Pain Symptom Manage 29:S10–S24CrossRefGoogle Scholar
  31. 31.
    Shou WZ, Pelzer M, Addison T, Jiang X, Naidong W (2002) J Pharm Biomed Anal 27:143–152CrossRefGoogle Scholar
  32. 32.
    Rook EJ, Huitema AD, van den BW, Hillebrand MJ, van Ree JM, Beijnen JH (2006) J Anal Toxicol 30:390–394Google Scholar
  33. 33.
    Whittington D, Kharasch ED (2003) J Chromatogr B 796:95–103CrossRefGoogle Scholar
  34. 34.
    de Jong LA, Kramer K, Kroeze MP, Bischoff R, Uges DR, Franke JP (2005) J Pharm Biomed Anal 39:964–971CrossRefGoogle Scholar
  35. 35.
    Kemp P, Sneed G, Kupiec T, Spiehler V (2002) J Anal Toxicol 26:504–512Google Scholar
  36. 36.
    Mi JQ, Zhang XX, Chang WB (2004) J Immunoassay Immunochem 25:57–70CrossRefGoogle Scholar
  37. 37.
    Ropero-Miller JD, Lambing MK, Winecker RE (2002) J Anal Toxicol 26:524–528Google Scholar
  38. 38.
    Meatherall R (2005) J Anal Toxicol 29:301–308Google Scholar
  39. 39.
    Hupka Y, Beike J, Roegener J, Brinkmann B, Blaschke G, Kohler H (2005) Int J Legal Med 119:121–128CrossRefGoogle Scholar
  40. 40.
    Bengtsson J, Jansson B, Hammarlund-Udenaes M (2005) Rapid Commun Mass Spectrom 19:2116–2122CrossRefGoogle Scholar
  41. 41.
    Wyman J, Bultman S (2004) J Anal Toxicol 28:260–263Google Scholar
  42. 42.
    Kerrigan S, Honey D, Baker G (2004) J Anal Toxicol 28:529–532Google Scholar
  43. 43.
    Crandall CS, Kerrigan S, Blau RL, Lavalley J, Zumwalt R, McKinney PE (2006) J Forensic Sci 51:413–420CrossRefGoogle Scholar
  44. 44.
    Lewis RJ, Johnson RD, Hattrup RA (2005) J Chromatogr B 822:137–145CrossRefGoogle Scholar
  45. 45.
    Leis HJ, Windischhofer W, Fauler G (2002) Rapid Commun Mass Spectrom 16:646–649CrossRefGoogle Scholar
  46. 46.
    Netriova J, Blahova E, Johanesova Z, Brandsteterova E, Lehotay J, Serdt K, Mocak J (2006) Pharmazie 61:528–534Google Scholar
  47. 47.
    Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NH (2004) Br J Anaesth 92:208–217CrossRefGoogle Scholar
  48. 48.
    Peters JW, Anderson BJ, Simons SH, Uges DR, Tibboel D (2005) Intensive Care Med 31:257–263CrossRefGoogle Scholar
  49. 49.
    Rook EJ, Hillebrand MJ, Rosing H, van Ree JM, Beijnen JH (2005) J Chromatogr B 824:213–221Google Scholar
  50. 50.
    Shou WZ, Chen YL, Eerkes A, Tang YQ, Magis L, Jiang X, Naidong W (2002) Rapid Commun Mass Spectrom 16:1613–1621CrossRefGoogle Scholar
  51. 51.
    Musshoff F, Trafkowski J, Kuepper U, Madea B (2006) J Mass Spectrom 41:633–640CrossRefGoogle Scholar
  52. 52.
    de la TR, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S (2004) Clin Pharmacokinet 43:157–185CrossRefGoogle Scholar
  53. 53.
    Kraemer T, Maurer HH (2002) Ther Drug Monit 24:277–289CrossRefGoogle Scholar
  54. 54.
    Musshoff F (2000) Drug Metab Rev 32:15–44CrossRefGoogle Scholar
  55. 55.
    de la TR, Farre M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Cami J (2004) Ther Drug Monit 26:137–144CrossRefGoogle Scholar
  56. 56.
    Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH (2003) J Mass Spectrom 38:659–676CrossRefGoogle Scholar
  57. 57.
    Kankaanpää A, Gunnar T, Ariniemi K, Lillsunde P, Mykkanen S, Seppala T (2004) J Chromatogr B 810:57–68CrossRefGoogle Scholar
  58. 58.
    Nishida M, Namera A, Yashiki M, Kojima T (2003) J Chromatogr B 789:65–71CrossRefGoogle Scholar
  59. 59.
    Nishida M, Namera A, Yashiki M, Kojima T (2002) Forensic Sci Int 125:156–162CrossRefGoogle Scholar
  60. 60.
    Frison G, Tedeschi L, Favretto D, Reheman A, Ferrara SD (2005) Rapid Commun Mass Spectrom 19:919–927CrossRefGoogle Scholar
  61. 61.
    Hidvegi E, Fabian P, Hideg Z, Somogyi G (2006) Forensic Sci Int 161:119–123CrossRefGoogle Scholar
  62. 62.
    Kronstrand R, Ahlner J, Dizdar N, Larson G (2003) J Anal Toxicol 27:135–141Google Scholar
  63. 63.
    Slawson MH, Taccogno JL, Foltz RL, Moody DE (2002) J Anal Toxicol 26:430–437Google Scholar
  64. 64.
    Mortier KA, Dams R, Lambert WE, De Letter EA, Van CS, De Leenheer AP (2002) Rapid Commun Mass Spectrom 16:865–870CrossRefGoogle Scholar
  65. 65.
    Nyström I, Trygg T, Woxler P, Ahlner J, Kronstrand R (2005) J Anal Toxicol 29:682–688Google Scholar
  66. 66.
    Apollonio LG, Pianca DJ, Whittall IR, Maher WA, Kyd JM (2006) J Chromatogr B 836:111–115CrossRefGoogle Scholar
  67. 67.
    Dams R, De Letter EA, Mortier KA, Cordonnier JA, Lambert WE, Piette MH, Van CS, De Leenheer AP (2003) J Anal Toxicol 27:318–322Google Scholar
  68. 68.
    Hendrickson HP, Milesi-Halle A, Laurenzana EM, Owens SM (2004) J Chromatogr B 806:81–87CrossRefGoogle Scholar
  69. 69.
    Segura M, Ortuno J, McLure JA, Pujadas M, Pizarro N, Farre M, Llebaria A, Joglar J, Segura J, de la TR (2002) J Chromatogr B 769:313–321CrossRefGoogle Scholar
  70. 70.
    Wood M, De BG, Samyn N, Morris M, Cooper DP, Maes RA, De Bruijn EA (2003) J Anal Toxicol 27:78–87Google Scholar
  71. 71.
    Maurer HH (2005) Anal Bioanal Chem 381:110–118CrossRefGoogle Scholar
  72. 72.
    Tomita M, Nakashima MN, Wada M, Nakashima K (2006) Biomed Chromatogr 20:1380–1385CrossRefGoogle Scholar
  73. 73.
    Peters FT, Kraemer T, Maurer HH (2002) Clin Chem 48:1472–1485Google Scholar
  74. 74.
    Peters FT, Samyn N, Lamers CT, Riedel WJ, Kraemer T, De BG, Maurer HH (2005) Clin Chem 51:1811–1822CrossRefGoogle Scholar
  75. 75.
    Peters FT, Samyn N, Wahl M, Kraemer T, De BG, Maurer HH (2003) J Anal Toxicol 27:552–559Google Scholar
  76. 76.
    Leis HJ, Rechberger GN, Fauler G, Windischhofer W (2003) Rapid Commun Mass Spectrom 17:569–575CrossRefGoogle Scholar
  77. 77.
    Pizarro N, Llebaria A, Cano S, Joglar J, Farre M, Segura J, de la TR (2003) Rapid Commun Mass Spectrom 17:330–336CrossRefGoogle Scholar
  78. 78.
    Pizarro N, Farre M, Pujadas M, Peiro AM, Roset PN, Joglar J, de la TR (2004) Drug Metab Dispos 32:1001–1007Google Scholar
  79. 79.
    Rasmussen LB, Olsen KH, Johansen SS (2006) J Chromatogr B 842:136–141CrossRefGoogle Scholar
  80. 80.
    Buechler J, Schwab M, Mikus G, Fischer B, Hermle L, Marx C, Gron G, Spitzer M, Kovar KA (2003) J Chromatogr B 793:207–222CrossRefGoogle Scholar
  81. 81.
    Rudaz S, Geiser L, Souverain S, Prat J, Veuthey JL (2005) Electrophoresis 26:3910–3920CrossRefGoogle Scholar
  82. 82.
    Brzezinski MR, Abraham TL, Stone CL, Dean RA, Bosron WF (1994) Biochem Pharmacol 48:1747–1755CrossRefGoogle Scholar
  83. 83.
    Kloss MW, Rosen GM, Rauckman EJ (1983) Mol Pharmacol 23:482–485Google Scholar
  84. 84.
    LeDuc BW, Sinclair PR, Shuster L, Sinclair JF, Evans JE, Greenblatt DJ (1993) Pharmacology 46:294–300CrossRefGoogle Scholar
  85. 85.
    Pellinen P, Kulmala L, Konttila J, Auriola S, Pasanen M, Juvonen R (2000) Arch Toxicol 74:511–520CrossRefGoogle Scholar
  86. 86.
    Kovacic P (2005) Med Hypotheses 64:350–356CrossRefGoogle Scholar
  87. 87.
    Kovacic P, Cooksy AL (2005) Med Hypotheses 64:357–366CrossRefGoogle Scholar
  88. 88.
    Cone EJ, Tsadik A, Oyler J, Darwin WD (1998) Ther Drug Monit 20:556–560CrossRefGoogle Scholar
  89. 89.
    Watanabe K, Hida Y, Matsunaga T, Yamamoto I, Yoshimura H (1993) Biol Pharm Bull 16:1041–1043Google Scholar
  90. 90.
    Zhang JY, Foltz RL (1990) J Anal Toxicol 14:201–205Google Scholar
  91. 91.
    Jacob P III, Lewis ER, Elias-Baker BA, Jones RT (1990) J Anal Toxicol 14:353–357Google Scholar
  92. 92.
    Kintz P, Sengler C, Cirimele V, Mangin P (1997) Hum Exp Toxicol 16:123–127CrossRefGoogle Scholar
  93. 93.
    Nakahara Y, Ishigami A (1991) J Anal Toxicol 15:105–109Google Scholar
  94. 94.
    Toennes SW, Fandino AS, Kauert G (1999) J Chromatogr B 735:127–132CrossRefGoogle Scholar
  95. 95.
    Fandino AS, Toennes SW, Kauert GF (2002) J Anal Toxicol 26:567–570Google Scholar
  96. 96.
    Paul BD, McWhorter LK, Smith ML (1999) J Mass Spectrom 34:651–660CrossRefGoogle Scholar
  97. 97.
    Paul BD, Lalani S, Bosy T, Jacobs AJ, Huestis MA (2005) Biomed Chromatogr 19:677–688CrossRefGoogle Scholar
  98. 98.
    Fandino AS, Karas M, Toennes SW, Kauert G (2002) J Mass Spectrom 37:525–532CrossRefGoogle Scholar
  99. 99.
    Lin SN, Walsh SL, Moody DE, Foltz RL (2003) Anal Chem 75:4335–4340CrossRefGoogle Scholar
  100. 100.
    Wang PP, Bartlett MG (1999) J Anal Toxicol 23:62–66Google Scholar
  101. 101.
    Fernandez P, Morales L, Vazquez C, Bermejo AM, Tabernero MJ (2006) Forensic Sci Int 161:31–35CrossRefGoogle Scholar
  102. 102.
    Fernandez P, Bujan L, Bermejo AM, Tabernero MJ (2004) J Appl Toxicol 24:283–287CrossRefGoogle Scholar
  103. 103.
    Cardona PS, Chaturvedi AK, Soper JW, Canfield DV (2006) Forensic Sci Int 157:46–56CrossRefGoogle Scholar
  104. 104.
    Alvarez I, Bermejo AM, Tabernero MJ, Fernandez P, Lopez P (2007) J Chromatogr B 845:90–94CrossRefGoogle Scholar
  105. 105.
    Laizure SC, Mandrell T, Gades NM, Parker RB (2003) Drug Metab Dispos 31:16–20CrossRefGoogle Scholar
  106. 106.
    Toennes SW, Fandino AS, Hesse FJ, Kauert GF (2003) J Chromatogr B 792:345–351CrossRefGoogle Scholar
  107. 107.
    Kolbrich EA, Barnes AJ, Gorelick DA, Boyd SJ, Cone EJ, Huestis MA (2006) J Anal Toxicol 30:501–510Google Scholar
  108. 108.
    Duer WC, Spitz DJ, McFarland S (2006) J Forensic Sci 51:421–425CrossRefGoogle Scholar
  109. 109.
    Gunnar T, Mykkanen S, Ariniemi K, Lillsunde P (2004) J Chromatogr B 806:205–219CrossRefGoogle Scholar
  110. 110.
    Concheiro M, de CA, Quintela O, Lopez-Rivadulla M, Cruz A (2006) J Chromatogr B 832:81–89CrossRefGoogle Scholar
  111. 111.
    Maralikova B, Weinmann W (2004) J Chromatogr B 811:21–30CrossRefGoogle Scholar
  112. 112.
    Allen KR, Azad R, Field HP, Blake DK (2005) Ann Clin Biochem 42:277–284CrossRefGoogle Scholar
  113. 113.
    Valaskovic GA, Utley L, Lee MS, Wu JT (2006) Rapid Commun Mass Spectrom 20:1087–1096CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Institute of Legal MedicineSaarland UniversityHomburg (Saar)Germany
  2. 2.Institute of Legal MedicineLudwig Maximilians UniversityMunichGermany

Personalised recommendations